Informing Low-acuity Emergency Department Patients of Non-emergent Resources

NCT ID: NCT06350266

Last Updated: 2025-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

6242 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-25

Study Completion Date

2024-12-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED)/encourage patients with high acuity visits to follow up with an appropriate Geisinger provider. In this campaign, patients will be assigned to receive or not receive outreach following ED discharge that is aligned with the goal. Outreach will occur via a text message, as well as information added to the patient's after visit summary, and will includecalls to action to see their Geisinger CMSL PCP either in person or virtually. The study will assess whether ED use differs across patients in different outreach conditions. It will also examine whether patients follow through on the message-specific calls to action in the messages differently across conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Emergency Service, Hospital

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Patients will be aware of their own messages but not of messages sent to other patients or in other arms.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

This arm will receive no intervention outside of usual care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Other Healthcare Resources

This arm will receive text messages suggesting alternatives to seeking care at a Geisinger emergency department such as seeing their Geisinger CMSL primary care provider in person or virtually (telehealth). Text suggesting these alternatives may also be included in a modified discharge paperwork packet.

Group Type EXPERIMENTAL

Information about healthcare resources

Intervention Type BEHAVIORAL

Text messages will be sent following discharge from the emergency department; text may also be modified in the (online and/or printed) discharge summary packet.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Information about healthcare resources

Text messages will be sent following discharge from the emergency department; text may also be modified in the (online and/or printed) discharge summary packet.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Text messages Discharge summary text Information

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>= 18 years of age
* Geisinger ED visit rated as low acuity (L4 or L5)
* Discharged from Geisinger ED in past 24 hours

Exclusion Criteria

* Cannot be contacted via the communication modality being used in the study (i.e., SMS), due to insufficient/missing contact information in the EHR or because the patient opted out
* Admitted to hospital
* Already included in intervention in past 365 days
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Geisinger Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amir Goren

Program Director, Behavioral Insights Team

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amir Goren, PhD

Role: PRINCIPAL_INVESTIGATOR

Geisinger Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geisinger Health System

Danville, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-0183

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Communication During Hospitalization About Resuscitation Trial
NCT02984124 ACTIVE_NOT_RECRUITING PHASE2/PHASE3
Text Message Appointment Reminders
NCT01676337 COMPLETED NA